MDS-PAS School for Young Neurologists Video Dinner February 21, 2015 Maria Eliza T. Freitas, MD Clinical Fellow In Movement Disorder University of Toronto.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

Loghman hospital – farhad mansouri. IS THE GRAY MATTER INVOLVED? level of conciousness content of conciousness.
An Unusual Gait Abnormality: Placing hands over head or pulling up pants improves walking MRN# Tara Kimbason, PGY 3 Feb 21, 2015.
Leslie Cloud, MD Department of Neurology Division of Movement Disorders Emory University School of Medicine.
PRESENTATION BY: PREMED III-GROUP4 DR.GURI.T.. INTRODUCTION HISTORY DISEASE DIAGNOSIS SYMPTOMS CAUSES PREVALENCE WORLDWIDE TREATMENT AND MANAGEMENT FUTURE.
Parkinson’s Disease (PD)
COMPREHENSIVE MANAGEMENT OF PARKINSONIAN PATIENTS WITH BOTULINUM TOXIN MAJA TROŠT DEPARTMENT FOR NEUROLOGY.
The PARticulars of Parkinson’s Disease
Parkinson’s Disease Dr Rachel Cary, Warwick Hospital.
Dr Helen Ling Queen Square Brain Bank for Neurological Disorders Institute of Neurology University College London Clinical aspects of MSA 2 nd UK MSA Research.
Basal Ganglia: PATHOLOGIES Emma & Amrit. PARKINSON’S HUNTONGTON’S BALISMUS/HEMIBALISMUS ATHETOSIS WILSON’S DISEASE.
Pelizaeus-Merzbacher Disease
MDS-PAS Video Presentation Chantale Branson, M.D. Boston University Medical Center.
Christopher Stephen, MD, MRCP (UK) Nutan Sharma, MD, PhD.
Diagnosis and Treatment of Parkinson’s Disease Jeff Bronstein, MD, PhD Professor of Neurology at UCLA Director of the SW PADRECC Director of UCLA Movement.
Parkinson’s Disease Shirley H. Wray, M.D., Ph.D., Professor of Neurology, Harvard Medical School Director, Unit for Neurovisual Disorders Massachusetts.
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
4 patients falling over. Mrs April Aged 62 Complains of tripping up when she walks on uneven surfaces Falls over and comes to hospital PMH COPD Vegan.
Human Genetic disorders
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
Video Competition MDS-PAS School For Young Neurologist Atlanta, GA, USA Case 1.
931-4 Convergence Insufficiency. History A 73-year old man with known PD for 10 years, complained of horizontal double vision for 18 months. He could.
Parkinson ’ s disease. Function Anatomy of Parkinson ’ s Disease.
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Neurological Manifestations of Wilson’s Disease Aleksandar Videnovic, MD, MSc Assistant Professor of Neurology Feinberg School of Medicine Northwestern.
Amyotrophic Lateral Sclerosis
Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.
Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
10 Second Case Studies Round 2: Degenerative Neurological Conditions.
Treatment of Parkinson Disease David Tran, 2013 Mercer University PharmD Candidate.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
Duchenne Muscular Dystrophy Jared Rubenstein. What Causes DMD? Caused by a mutation in a gene, called the DMD gene that can be inherited in families in.
1 From Cause to Movement Shaping a World Without Alzheimer’s Through Advocacy, Volunteerism, Referral and Science Ian Kremer, Esq. Advocacy & Outreach.
Richard Leckey Oct 2,2015.  Faculty: Dr. Richard Leckey  Relationships with commercial interests:  Biogen  Merck  Serono  Novartis  Allergen CFPC.
Amyotrophic Lateral Sclerosis. Motor Neuron Disease Terminology Lower motor neuron Upper motor neuron Progressive Muscular Atrophy Amyotrophic Lateral.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
SCHIZOPHRENIA 2 nd most frequent diagnosis of patients y/o.
By: Alejandro Navarro and Andrea Ors. Content Introduction What is Parkinson's disease? What causes the disease? History Main symptoms Treatment Statistics.
A 53-year-old male with clumsiness Leonidas Arvanitis, M.D. Neuropathology Fellow, PGY-6.
Amyotrophic Lateral Sclerosis (ALS)
Teaching NeuroImages A 54-year-old man with progressive muscle weakness, hand tremor, tongue and perioral fasciculation Neurology Resident and Fellow Section.
By Katelyn Chaimson and Sean Guyot
Parkinson's disease By Colby Allen. symptoms Mild to major tremors. Rigidity or joint stiffness Bradykinesia or slowness of movement Postural instability.
Neurogenetic Self-Assessment John K. Fink, M.D., Professor, Department of Neurology, University of Michigan Feb. 24, 2009 Movement disorders: Parkinson’s,
DAY 2 Unit 3 Inheritance and Molecular Genetics 1.
Parkinson’s Disease Sheila Mulhern. Parkinson’s Disease Stats (PDF)  One million Americans live with Parkinson's disease, - more than the combined number.
Pathogenesis and pathology of parkinsonism
Teaching NeuroImages Neurology Resident and Fellow Section A 77 year-old woman with Parkinson’s disease exhibits re- emergent jaw tremor. © 2015 American.
Huntington’s Disease BY: SAM DAVIS, SABRINA TRAN, MYA LUNA, MYLES BLACKWELL AND EAMONN DUENSING.
Deep Brain Stimulation Surgery in India. Deep Brain Stimulation can help to treat with many symptoms caused by the following movement disorders: Parkinson’s.
Management of Parkinson’s disease (in the acute medical ward) C. M. James MD FRCP FAcadMEd Consultant Physician Withybush Hospital, Pembrokeshire.
Differential Diagnosis of Parkinsonism
Hypotonia, neuropathies and myopathies
Parkinson’s Disease By: Taylor Hawkins, Ana McGhee, and Morgan Zander.
Chapter 14 Neurocognitive Disorders
Frontotemporal Lobar Degeneration:
PARKINSON’S DISEASE LUKE CARROLL & LAUREN DESROCHES.
Involuntary movements in Parkinson’s disease: not always what it seems
A 15 YEAR OLD BOY WITH AN ASCENDING SPASTIC PARALYSIS
Parkinson’s Disease Celsey and Chylee.
Neurological History and Exam
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
Atypical Parkinsonian Syndromes
Lucas McDuff and Meghan Mumpower
Lucas McDuff and Meghan Mumpower
Deep Brain Stimulation: What, When, Why, How
Presentation transcript:

MDS-PAS School for Young Neurologists Video Dinner February 21, 2015 Maria Eliza T. Freitas, MD Clinical Fellow In Movement Disorder University of Toronto Toronto Western Hospital

History 40 year-old male, right-handed Age of onset: 35 years Tremor and lack of dexterity in both hands Worse in the left side Slow and unsteady gait (2 falls) He denied: - Symptoms of dysautonomia, - Cognitive/ behavior impairment - Dysarthria, dysphagia Past medical history: hypertension, dyslipidemia and gout Current medications: Crestor, Atenolol, Allopurinol

Video

Physical Exam No cognitive impairment or apraxia. Cranial nerves: Eye movements were full. There were slow saccades and normal pursuit/VOR. No nystagmus. Motor exam showed normal muscle bulk and strength throughout. Reflexes were normal. Moderate rigidity in the upper limbs (worse in the left side). Mild rigidity in the lower limbs. No sensory abnormalities.

Differential Diagnosis Brain MRI: Normal Normal copper studies Investigation Early onset Parkinsonism: Parkin (PARK2) PINK1 (PARK6) DJ-1-associated parkinsonism (PARK7) Neurodegeneration with brain iron accumulation (NBIA) Spinocerebellar atrophy (SCA) types 2 and 3 X-linked dystonia-parkinsonism/Lubag (DYT3) Wilson’s disease Dopa-responsive dystonia (DYT5)

Summary Early onset Parkinsonism (35yo) Asymmetric rest, postural and kinetic tremor (atypical tremor - dystonic) Postural instability Levodopa reduced hand tremor (no benefit for others symptoms) Not aware of on-off motor fluctuations Diphasic dyskinesia Mode of inheritance: Sex-linked recessive disorder History of ancestral roots from Panay Islands (Philippines)

Final Diagnosis Target mutation analysis found the disease-specific single-nucleotide change 3 (DSC3) in the TAF1/DYT3 gene: X-linked recessive Dystonia-Parkinsonism: DYT3 or Lubag Disease

Phenomenology of the Tremor Marsden’s Book of Movement Disorders, 2011

DYT3 - Lubag Lee et al (2011): reviewed 505 cases Age of onset is years M ean duration of illness is 16 years and mean age at death is 55.6 years. Onset with dystonia: 94.3% (focal) Onset with parkinsonism: 5.7% Focal dystonia spreads in 97% of the time and generalizes within 5 years in 84% Dyskinesia are unusual: levodopa-induced x clinical feature of Lubag Women: milder course and different phenotype Diagnosis: DSC3 mutation on Xq13 Treatment: oral medications, Botulinum toxin, DBS Dystonic phaseCombined dystonia-Parkinsonian phase parkinsonian phase Pasco et al, 2011 Lee et al, 2011

Taking Home Messages DYT3 is a sex-linked recessive dystonia-parkinsonism This case has shown mainly parkinsonian symptoms with atypical features: dystonic tremor but no clear focal dystonia and also unusual dyskinesia (levodopa-induced or Lubag's dyskinesia?) DYT3 should be considered in men with progressive dystonia/parkinsonism, positive family history and ancestral roots from Philippine. Parkinsonism may be the only early feature in male patients with XDP preceding the onset of dystonia. Symptomatic carriers (women) have a milder phenotype, older age of onset, and mild parkinsonism with or without dystonia. Evidente et al., 2004